Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
---|---|---|---|---|---|---|---|
1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 | ||||
2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 | ||||
3. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 | ||||
4. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma | Leeratanakachorn, N Luvira, V Tipwaratorn, T Theeragul, S Jarearnrat, A Titapun, A Srisuk, T Kamsa-Ard, S Pugkhem, A Khuntikeo, N Pairojkul, C Bhudhisawasdi, V |
2021 | ||||
5. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. | Sureerat Padthaisong Jutarop Phetcharaburanin Poramate Klanrit Jia Li Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Arporn Wangwiwatsin Panupong Mahalapbutr Watcharin Loilome |
2021 | ||||
6. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 | ||||
7. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 | ||||
8. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 | Count | 6 | 8 | 7 | 0 |
Title | Authors | Year | Publication name | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | รวม | ||||||
1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 |
OncoTargets and Therapy (11), pp. 7019-7029 |
||||||||
2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 |
PLoS ONE 9 (14), pp. |
||||||||
3. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 |
Oncology Letters 1 (19), pp. 930-942 |
||||||||
4. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma | Titapun, A. Kamsa-Ard, S. Pugkhem, A. Khuntikeo, N. Pairojkul, C. Bhudhisawasdi, V. |
2021 |
International Journal of Hepatology (2021), pp. |
||||||||
5. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Dokduang, H. Padthaisong, S. Namwat, N. Klanrit, P. Phetcharaburanin, J. Wangwiwatsin, A. Khampitak, T. Koonmee, S. Titapun, A. Khuntikeo, N. Loilome, W. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
6. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 |
Frontiers in Public Health (10), pp. |
Title | Authors | Year | Journal title | ||
---|---|---|---|---|---|
1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 |
OncoTargets and therapy (11), pp. 7019-7029 |
|
2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 |
PloS one 9 (14), pp. e0222140 |
|
3. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. | Chanakankun, R Proungvitaya, T Chua-On, D Limpaiboon, T Roytrakul, S Jusakul, A Titapun, A Jarearnrat, A Proungvitaya, S |
2020 |
Oncology letters 1 (19), pp. 930-942 |
|
4. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 30 |
|
5. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Tomacha, J Dokduang, H Padthaisong, S Namwat, N Klanrit, P Phetcharaburanin, J Wangwiwatsin, A Khampitak, T Koonmee, S Titapun, A Jarearnrat, A Khuntikeo, N Loilome, W |
2021 |
Frontiers in pharmacology (12), pp. 696961 |
|
6. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma. | Leeratanakachorn, N Luvira, V Tipwaratorn, T Theeragul, S Jarearnrat, A Titapun, A Srisuk, T Kamsa-Ard, S Pugkhem, A Khuntikeo, N Pairojkul, C Bhudhisawasdi, V |
2021 |
International journal of hepatology (2021), pp. 1625717 |
|
7. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 |
Frontiers in public health (9), pp. 766455 |
|
8. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 |
Frontiers in public health (10), pp. 766023 |
Title | Authors | Year | Journal title | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | รวม | ||||||
1. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway | Sasikamon Khophai Malinee Thanee Anchalee Techasen Nisana Namwat Poramate Klanrit Attapol Titapun Apiwat Jarearnrat Prakasit Sa-Ngiamwibool Watcharin Loilome |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 7019.0-7029.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
2. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Manida Suksawat Poramate Klanrit Jutarop Phetcharaburanin Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Prakasit Sa-ngiamwibool Anchalee Techasen Watcharin Loilome |
2019 |
PLOS ONE 9.0 (14.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
3. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 |
ONCOLOGY LETTERS 1.0 (19.0), pp. 930.0-942.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
4. | Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma | Natwutpong Leeratanakachorn Vor Luvira Theerawee Tipwaratorn Suapa Theeragul Apiwat Jarearnrat Attapol Titapun Tharatip Srisuk Supot Kamsa-ard Ake Pugkhem Narong Khuntikeo Chawalit Pairojkul Vajarabhongsa Bhudhisawasdi |
2021 |
INTERNATIONAL JOURNAL OF HEPATOLOGY (2021.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
5. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Sureerat Padthaisong Jutarop Phetcharaburanin Poramate Klanrit Jia Li Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Arporn Wangwiwatsin Panupong Mahalapbutr Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
6. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Yingpinyapat Kittirat Jutarop Phetcharaburanin Bundit Promraksa Thanaporn Kulthawatsiri Arporn Wangwiwatsin Poramate Klanrit Sakkarn Sangkhamanon Apiwat Jarearnrat Suyanee Thongchot Panupong Mahalapbutr Watcharin Loilome Hideyuki Saya Nisana Namwat |
2021 |
FRONTIERS IN PUBLIC HEALTH (9.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
7. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 |
FRONTIERS IN PHARMACOLOGY (12.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Title | Authors | Year | Journal title |
---|
ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
---|